FMEDvsGNMXETF Comparison
VS
Fidelity Disruptive Medicine ETF (FMED) belongs to the Multiple Trends segment. Corgi Genomics & Precision Medicine ETF (GNMX) is part of the BioTech & Genomics segment. Both ETFs have the same top 1 sector exposures: Healthcare. FMED is more expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.35% for GNMX. Run a side-by-side ETF comparison of FMED and GNMX below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
FMED vs GNMX performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/21/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FMED GNMX | -2.40%+2.85% | +21.48%+31.49% | +17.43%n/a | +29.04%n/a | +43.82%n/a | n/an/a |
| Flows | FMED GNMX | -+$1M | -+$761K | -$17M- | -$14M- | -$3M- | -- |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FMED GNMX | +24.66%+33.97% | +21.06%n/a | +19.25%n/a | n/an/a |
| Max drawdown | FMED GNMX | -7.15%-8.53% | -17.78%n/a | -19.20%n/a | n/an/a |
| Max drawdown duration | FMED GNMX | 29d32d | 212dn/a | 267dn/a | n/an/a |
Trading data
FMED | GNMX | |
Last sale | ||
| Previous close 09/21/2026 | ||
| Consolidated volume 09/21/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
FMED | GNMX | |
|---|---|---|
| Last price | – | – |
| 1D performance | – | – |
| AuM | $51.66 M | $2.76 M |
| E/R | 0.5% | 0.35% |
Characteristics
FMED | GNMX | |
|---|---|---|
| Management strategy | Active | Active |
| Provider | Fidelity | Corgi Funds |
| Benchmark | - | - |
| N° of holdings | 74 | 57 |
| Asset class | - | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 12, 2023 | May 6, 2026 |
| ESG | No | No |
Advertisement
Exposure
Countries
FMED
USA
83.4%
Other
16.6%
GNMX
USA
87.58%
Other
12.42%
Sectors
FMED
Healthcare
100%
Other
0%
GNMX
Healthcare
96.78%
Other
3.22%
Diversification
FMED
Total weight of top 15 holdings out of 15
43.09%
GNMX
Total weight of top 15 holdings out of 15
55.56%
Top 15 holdings
Data as of July 31, 2026
FMED
10X Genomics, Inc.
4.48%
Thermo Fisher Scientific, Inc.
3.98%
Danaher Corp.
3.86%
Lifestance Health Group, Inc.
3.15%
Alnylam Pharmaceuticals, Inc.
3.10%
argenx SE
2.99%
Cogent Biosciences, Inc.
2.98%
Revolution Medicines, Inc.
2.85%
Illumina, Inc.
2.62%
Intuitive Surgical, Inc.
2.34%
Kymera Therapeutics, Inc.
2.29%
UnitedHealth Group, Inc.
2.24%
Ascendis Pharma A/S
2.12%
Kiniksa Pharmaceuticals International Plc
2.06%
UCB SA
2.03%
GNMX
Thermo Fisher Scientific, Inc.
9.28%
Vertex Pharmaceuticals, Inc.
6.75%
Illumina, Inc.
4.56%
Guardant Health, Inc.
4.26%
Revolution Medicines, Inc.
3.92%
Incyte Corp.
3.38%
Moderna, Inc.
3.06%
Genmab A/S
2.96%
Alnylam Pharmaceuticals, Inc.
2.77%
Bio-Techne Corp.
2.67%
10X Genomics, Inc.
2.58%
BioMarin Pharmaceutical, Inc.
2.55%
Arrowhead Pharmaceuticals, Inc.
2.34%
Krystal Biotech, Inc.
2.30%
QIAGEN NV
2.18%
Frequently asked questions about FMED and GNMX
Which ETF is bigger: FMED or GNMX?
As of September 21, 2026, FMED holds $51.66 M in assets under management (AUM), while GNMX manages $2.76 M.
What sectors do the FMED and GNMX ETFs invest in?
FMED leans toward sectors like Healthcare. Meanwhile, GNMX focuses on Healthcare.
What are the top holdings of the FMED ETF and GNMX ETF?
FMED top holdings include 10X Genomics, Inc., Thermo Fisher Scientific, Inc. and Danaher Corp.. GNMX holds in its top three: Thermo Fisher Scientific, Inc., Vertex Pharmaceuticals, Inc. and Illumina, Inc..
Which ETF is more diversified: FMED or GNMX?
FMED holds 74 securities with 43.09% of its assets in the top 15. GNMX has 57 securities and a top 15 weight of 55.56%.
Advertisement
Advertisement
